Here, we present de-identified electronic health record data from the TriNetX Research Database analyzing the risks associated with GLP-1 receptor agonist and SGLT2 inhibitor medication use among individuals with type 2 diabetes mellitus. Here, SLC5A2 is linked to type 2 diabetes mellitus.